The IL-33/ST2 Axis Protects Retinal Ganglion Cells by Modulating the Astrocyte Response After Optic Nerve Injury.
10.1007/s12264-024-01279-y
- Author:
Zhigang QIAN
1
;
Mengya JIAO
1
;
Na ZHANG
1
;
Xuhuan TANG
1
;
Shiwang LIU
1
;
Feng ZHANG
1
;
Chenchen WANG
2
;
Fang ZHENG
3
Author Information
1. Department of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China.
2. National Demonstration Center for Experimental Basic Medical Education, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
3. Department of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China. zhengfangtj@hust.edu.cn.
- Publication Type:Journal Article
- Keywords:
Astrocyte;
IL-33;
Neuroprotection;
Optic nerve injury;
Retinal neurodegeneration;
ST2
- MeSH:
Animals;
Interleukin-33/genetics*;
Interleukin-1 Receptor-Like 1 Protein/genetics*;
Optic Nerve Injuries/pathology*;
Retinal Ganglion Cells/pathology*;
Astrocytes/pathology*;
Mice;
Mice, Knockout;
Mice, Inbred C57BL;
Neuroprotection/physiology*
- From:
Neuroscience Bulletin
2025;41(1):61-76
- CountryChina
- Language:English
-
Abstract:
IL-33 and its receptor ST2 play crucial roles in tissue repair and homeostasis. However, their involvement in optic neuropathy due to trauma and glaucoma remains unclear. Here, we report that IL-33 and ST2 were highly expressed in the mouse optic nerve and retina. Deletion of IL-33 or ST2 exacerbated retinal ganglion cell (RGC) loss, retinal thinning, and nerve fiber degeneration following optic nerve (ON) injury. This heightened retinal neurodegeneration correlated with increased neurotoxic astrocytes in Il33-/- mice. In vitro, rIL-33 mitigated the neurotoxic astrocyte phenotype and reduced the expression of pro-inflammatory factors, thereby alleviating the RGC death induced by neurotoxic astrocyte-conditioned medium in retinal explants. Exogenous IL-33 treatment improved RGC survival in Il33-/- and WT mice after ON injury, but not in ST2-/- mice. Our findings highlight the role of the IL-33/ST2 axis in modulating reactive astrocyte function and providing neuroprotection for RGCs following ON injury.
